Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 148560quant ESG Integration Strategy Fund
Disclosed for 71 months, Nov 2020 to Sep 2026.
Portfolio value
₹215 Cr
up ₹14.3 Cr vs Dec 2023
- Stocks held
- 14
- down 1 vs Dec 2023
- Top 10 weight
- 72.2%
- of the portfolio in its ten largest
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In January 2024 it disclosed 14 stocks worth ₹215 Cr, up ₹14.3 Cr from Dec 2023. Its largest positions were Reliance Industries Limited (10.4%), Jio Financial Services Limited (9.6%), RBL Bank Limited (8.4%); the ten largest together made up 72.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 30.3% of its equity. Cash and debt stood at 6.7%. Compared with Dec 2023 the fund entered 4 new stocks and exited 5.
Against 229 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
83%
Holds more cash than 83% of peers
What these mean: concentration · cash
Holdings in January 2024
Download CSVEvery line the fund disclosed, with the change against Dec 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Reliance Industries Limited | 10.37% | up 0.31 pts | ₹22.3 Cr | up ₹2.1 Cr | Added |
| Jio Financial Services Limited | 9.56% | down 0.05 pts | ₹20.5 Cr | up ₹1.3 Cr | Added |
| RBL Bank Limited | 8.41% | down 1.25 pts | ₹18 Cr | down ₹1.3 Cr | Trimmed |
| Britannia Industries Limited | 8.23% | up 5.57 pts | ₹17.7 Cr | up ₹12.3 Cr | Added |
| Biocon Limited | 8.13% | up 8.13 pts | ₹17.4 Cr | up ₹17.4 Cr | New |
| Sun Pharmaceutical Industries Limited | 5.84% | up 0.29 pts | ₹12.5 Cr | up ₹1.4 Cr | Added |
| Life Insurance Corporation Of India | 5.75% | up 1.18 pts | ₹12.3 Cr | up ₹3.2 Cr | Added |
| National Aluminium Company Limited | 5.55% | up 5.55 pts | ₹11.9 Cr | up ₹11.9 Cr | New |
| Jindal Steel & Power Limited | 5.47% | down 3.12 pts | ₹11.7 Cr | down ₹5.5 Cr | Trimmed |
| Lupin Limited | 4.91% | up 0.29 pts | ₹10.5 Cr | up ₹1.3 Cr | Added |
| Aurobindo Pharma Limited 29/02/2024 Derivative | 4.84% | up 4.84 pts | ₹10.4 Cr | up ₹10.4 Cr | New |
| 91 Days Treasury Bill 14-Mar-2024 Debt | 4.62% | down 0.30 pts | ₹9.9 Cr | up ₹6 L | Added |
| Aurobindo Pharma Limited | 3.54% | down 0.03 pts | ₹7.6 Cr | up ₹44 L | Added |
| Oracle Financial Services Software Limited | 3.04% | up 3.04 pts | ₹6.5 Cr | up ₹6.5 Cr | New |
| Mphasis Ltd 29/02/2024 Derivative | 2.43% | up 2.43 pts | ₹5.2 Cr | up ₹5.2 Cr | New |
| Jubilant Pharmova Limited | 2.13% | down 0.05 pts | ₹4.6 Cr | up ₹21 L | Added |
| Cash, TREPS & receivables | 2.10% | up 5.77 pts | ₹4.5 Cr | up ₹11.9 Cr | Added |
| Indusind Bank Limited 29/02/2024 Derivative | 1.98% | up 1.98 pts | ₹4.3 Cr | up ₹4.3 Cr | New |
| Apollo Hospitals Enterprise Ltd 29/02/2024 Derivative | 1.49% | up 1.49 pts | ₹3.2 Cr | up ₹3.2 Cr | New |
| Sun Pharmaceutical Industries Limited 29/02/2024 Derivative | 1.43% | up 1.43 pts | ₹3.1 Cr | up ₹3.1 Cr | New |
| MphasiS Limited | 0.18% | up 0.18 pts | ₹39 L | up ₹39 L | New |
What changed, Dec 2023 to Jan 2024
New New positions (4)
- Biocon Limited8.1% · ₹17.4 Cr
- National Aluminium Company Limited5.5% · ₹11.9 Cr
- Oracle Financial Services Software Limited3.0% · ₹6.5 Cr
- MphasiS Limited0.2% · ₹39 L
Exited Exited (5)
- Indian Bankwas 6.9% · ₹13.9 Cr
- GlaxoSmithKline Pharmaceuticals Limitedwas 6.9% · ₹13.9 Cr
- Aster DM Healthcare Limitedwas 6.9% · ₹13.7 Cr
- India Shelter Finance Corporation Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2023, the weight rose most in Food Products (+7.1 pts) and Non - Ferrous Metals (+6.8 pts), and fell most in Banks (−10.2 pts) and Healthcare Services (−7.9 pts).
- Food Products3.1% → 10.2%+7.1 pts
- Non - Ferrous Metals0.0% → 6.8%new+6.8 pts
- IT - Software0.0% → 4.0%new+4.0 pts
- Pharmaceuticals & Biotechnology26.4% → 30.3%+3.9 pts
- Insurance5.3% → 7.1%+1.8 pts
- Petroleum Products11.6% → 12.8%+1.2 pts
- Banks20.6% → 10.4%−10.2 pts
- Healthcare Services7.9% → 0.0%exited−7.9 pts
- Finance15.2% → 11.8%−3.4 pts
- Ferrous Metals9.9% → 6.7%−3.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2021 | Jan 2023 | Jul 2023 | Oct 2023 | Dec 2023 | Jan 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 26.4% | — | 20.9% | 11.9% | 26.4% | 30.3% |
| Petroleum Products | 9.4% | 9.3% | 11.0% | 17.4% | 11.6% | 12.8% |
| Finance | 1.5% | 1.5% | 1.1% | 13.0% | 15.2% | 11.8% |
| Banks | — | 28.6% | 10.8% | 10.9% | 20.6% | 10.4% |
| Food Products | 4.5% | 7.9% | 13.0% | — | 3.1% | 10.2% |
| Insurance | — | 6.9% | — | — | 5.3% | 7.1% |
| Non - Ferrous Metals | — | 4.0% | — | — | — | 6.8% |
| Ferrous Metals | — | 6.3% | 7.1% | 10.5% | 9.9% | 6.7% |
| IT - Software | 18.5% | 3.2% | — | — | — | 4.0% |
Allocation in Jan 2024change vs Dec 2023
- Pharmaceuticals & Biotechnology (5)30.3%▲ 3.9 pts
- Petroleum Products (1)12.8%▲ 1.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2024
6.7%
▲ 5.5 pts vs Dec 2023
- Cash alone
- 2.1%
- cash and net receivables
- A year earlier
- 3.8%
- Jan 2023 · now ▲ 2.9 pts
- Last 12 months
- 0.1% – 17.8%
- lowest to highest · record 17.8% in Aug 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.